Theratechnologies Inc.
DelistedCIK 1512717fmd_0K8DH72F5C4WKK9SVAPWS5E6B5Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Dec 01, 2017 to Nov 30, 2024, 7 periods
Latest annual · FY2024
Millions- Total revenues
- 86
- Gross profit
- 65
- Operating income
- 8
- Net income
- (8)
- Free cash flow
- 2
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- +7.1%
- Revenue, 5 yearsFY2019 to FY2024
- +6.3%
- Net income, 5 yearsFY2019 to FY2024
- n/m
Theratechnologies Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $85.9 million | $81.8 million | +5% | 20-F 2025-02-26 · proof |
| Gross profit | $65.4 million | $62.1 million | +5.3% | 20-F 2025-02-26 · proof |
| Operating income | $8.2 million | -$10.6 million | 20-F 2025-02-26 · proof | |
| Net income | -$8.3 million | -$24 million | 20-F 2025-02-26 · proof | |
| Cash from operating activities | $2.4 million | -$5.7 million | 20-F 2025-02-26 · proof | |
| Free cash flow | $2.4 million | -$6 million | 20-F 2025-02-26 · proof | |
| Total assets | $53.3 million | $77.8 million | -31.4% | 20-F 2025-02-26 · proof |
| Total liabilities | $78.6 million | $98.6 million | -20.3% | 20-F 2025-02-26 · proof |
| Cash and cash equivalents | $15.9 million | $34.1 million | -53.4% | 20-F 2025-02-26 · proof |
| Total debt | $44.4 million | $58 million | -23.4% | 20-F 2025-02-26 · proof |
- What was Theratechnologies Inc.'s revenue in fiscal 2024?
- Theratechnologies Inc. reported revenue of $85.9 million for fiscal 2024 (the year ended Nov 30, 2024), against $81.8 million the year before (+5%). Source: the 20-F filed with the SEC on Feb 26, 2025. SEC
- What was Theratechnologies Inc.'s gross profit in fiscal 2024?
- Theratechnologies Inc. reported gross profit of $65.4 million for fiscal 2024 (the year ended Nov 30, 2024), against $62.1 million the year before (+5.3%). Source: the 20-F filed with the SEC on Feb 26, 2025. SEC
- What was Theratechnologies Inc.'s operating income in fiscal 2024?
- Theratechnologies Inc. reported operating income of $8.2 million for fiscal 2024 (the year ended Nov 30, 2024), against -$10.6 million the year before. Source: the 20-F filed with the SEC on Feb 26, 2025. SEC
- What was Theratechnologies Inc.'s net income in fiscal 2024?
- Theratechnologies Inc. reported net income of -$8.3 million for fiscal 2024 (the year ended Nov 30, 2024), against -$24 million the year before. Source: the 20-F filed with the SEC on Feb 26, 2025. SEC
- What was Theratechnologies Inc.'s cash from operating activities in fiscal 2024?
- Theratechnologies Inc. reported cash from operating activities of $2.4 million for fiscal 2024 (the year ended Nov 30, 2024), against -$5.7 million the year before. Source: the 20-F filed with the SEC on Feb 26, 2025. SEC
- What was Theratechnologies Inc.'s free cash flow in fiscal 2024?
- Theratechnologies Inc. reported free cash flow of $2.4 million for fiscal 2024 (the year ended Nov 30, 2024), against -$6 million the year before. Source: the 20-F filed with the SEC on Feb 26, 2025. SEC
- What are Theratechnologies Inc.'s total assets?
- As of Nov 30, 2024, Theratechnologies Inc. reported total assets of $53.3 million, against $77.8 million a year earlier (-31.4%). Source: the 20-F filed with the SEC on Feb 26, 2025. SEC
- What are Theratechnologies Inc.'s total liabilities?
- As of Nov 30, 2024, Theratechnologies Inc. reported total liabilities of $78.6 million, against $98.6 million a year earlier (-20.3%). Source: the 20-F filed with the SEC on Feb 26, 2025. SEC
- What are Theratechnologies Inc.'s cash and cash equivalents?
- As of Nov 30, 2024, Theratechnologies Inc. reported cash and cash equivalents of $15.9 million, against $34.1 million a year earlier (-53.4%). Source: the 20-F filed with the SEC on Feb 26, 2025. SEC
- What is Theratechnologies Inc.'s total debt?
- As of Nov 30, 2024, Theratechnologies Inc. reported total debt of $44.4 million, against $58 million a year earlier (-23.4%). Source: the 20-F filed with the SEC on Feb 26, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1512717&period_type=annual&limit=5"Information only, not investment advice.